Retention in care within 1 year of initial HIV care visit in a multisite US cohort: Who's in and who's out?

Journal of the International Association of Providers of AIDS Care

Volumn 13, Issue 3, 2014, Pages 232-241

  Tedaldi, Ellen M ^a   Richardson, James T ^b   Debes, Rachel ^b   Young, Benjamin ^c,d   Chmiel, Joan S ^e   Durham, Marcus D ^f   Brooks, John T ^f   Buchacz, Kate ^f  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CERNER CORPORATION   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

antiretroviral adherence; HIV infection; retention

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT CARE; PRIORITY JOURNAL;

ANTIRETROVIRAL ADHERENCE; HIV INFECTION; RETENTION;

ADULT; AMBULATORY CARE FACILITIES; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84900341587     PISSN: 23259574     EISSN: 23259582     Source Type: Journal    
DOI: 10.1177/2325957413514631     Document Type: Article

References (57)

1. Office of National HIV/AIDS Policy. National HIV/AIDS strategy for the United States. http://www.whitehouse.gov/administration/eop/onap/nhas/. Accessed October 25, 2013.
2. Giordano TP, Gifford AL, White AC, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007 ; 44 (11). 1493-1499
3. Tripathi A, Youmans E, Gibson JJ, Duffus WA. The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study. AIDS Res Hum Retroviruses. 2011 ; 27 (7). 751-758
4. Mugavero MJ, Lin HY, Allison JJ, et al. Racial disparities in HIV virologic failure: do missed visits matter?. J Acquir Immune Defic Syndr. 2009 ; 50 (1). 100-108
5. Berg M, Safren S, Mimiaga M, Grasso C, Boswell S, Mayer K. Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic. AIDS Care. 2007 ; 17 (7). 902-907
6. Mugavero MJ, Amico KR, Westfall AO, et al. Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J Acquir Immune Defic Syndr. 2012 ; 59 (1). 86-93
7. Tedaldi EM, Baker RK, Moorman AC, et al. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis. 2004 ; 38 (10). 1478-1484
8. Silverberg MJ, Leyden W, Quesenberry CP, Horberg MA. Race/Ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med. 2009 ; 24 (9). 1065-1072
9. Gallant JE, Adimora AA, Carmichael JK, et al. Essential components of effective HIV care: a policy paper of the HIV medicine association of the infectious diseases society of America and the Ryan white medical providers coalition. Clin Infect Dis. 2011 ; 53 (11). 1043-1050
10. Horberg MA, Aberg JA, Cheever LW, Renner P, Kaleba EO, Asch SM. Development of national and multiagency HIV care quality measures. Clin Infect Dis. 2010 ; 51 (6). 732-738
11. Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012 ; 156 (11). 817-833
12. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2009 ; 49 (5). 651-681
13. Monitoring HIV Care in the United States: Indicators and Data Systems. Washington, DC: The National Academies Press ; 2012 :
14. Yehia BR, Fleishman JA, Metlay JP, et al. Comparing different measures of retention in outpatient HIV care. AIDS. 2012 ; 26 (9). 1131-1139
15. Dombrowski JC, Kent JB, Buskin SE, Stekler JD, Golden MR. Population-based metrics for the timing of HIV diagnosis, engagement in HIV care, and virologic suppression. AIDS. 2012 ; 26 (1). 77-86
16. Department of Health and Human Services. HIV/AIDS Bureau (HAB) HIV performance measures. http://hab.hrsa.gov/deliverhivaidscare/habperformmeasures. html Accessed October 25, 2013.
17. Giordano TP, Hartman C, Gifford AL, Backus LI, Morgan RO. Predictors of retention in HIV care among a national cohort of US veterans. HIV Clin Trials. 2009 ; 10 (5). 299-305
18. Gardner EM, McLees MP, Steiner JF, Del RC, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011 ; 52 (6). 793-800
19. Vital signs: HIV prevention through care and treatment - United States. MMWR Morb Mortal Wkly Rep. 2011 ; 60 (47). 1618-1623
20. Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS. 2010 ; 24 (17). 2665-2678
21. Fleishman JA, Yehia BR, Moore RD, Korthuis P, Gebo KA. Establishment, retention, and loss to follow-up in outpatient HIV care. J Acquir Immune Defic Syndr. 2012 ; 60 (3). 249-259
22. Torian LV, Wiewel EW. Continuity of HIV-related medical care, New York City, 2005-2009: do patients who initiate care stay in care?. AIDS Patient Care STDS. 2011 ; 25 (2). 79-88
23. Hsu LC, Chen M, Kali J, Pipkin S, Scheer S, Schwarcz S. Assessing receipt of medical care and disparity among persons with HIV/AIDS in San Francisco, 2006-2007. AIDS Care. 2011 ; 23 (3). 383-392
24. Hall HI, Gray KM, Tang T, Li J, Shouse L, Mermin J. Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr. 2012 ; 60 (1). 77-82
25. Wohl AR, Galvan FH, Myers HF, et al. Do social support, stress, disclosure and stigma influence retention in HIV care for Latino and African American men who have sex with men and women?. AIDS Behav. 2011 ; 15 (6). 1098-1110
26. Losina E, Schackman BR, Sadownik SN, et al. Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis. 2009 ; 49 (10). 1570-1578
27. Traeger L, O'Cleirigh C, Skeer MR, Mayer KH, Safren SA. Risk factors for missed HIV primary care visits among men who have sex with men. J Behav Med. 2012 ; 35 (5). 548-556
28. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services. Published on February 12, 2013. http://aidsinfo.nih.gov/guidelines. Accessed October 25, 2013.
29. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services. Published on November 3, 2008.http://aidsinfo.nih.gov/guidelines. Accessed October 25, 2013.
30. Geng EH, Hare CB, Kahn JO, et al. The Effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/muL in a public health setting. Clin Infect Dis. 2012 ; 55 (12). 1690-1697
31. Grimes RM, Grimes DE. Readiness: the state of the science (or the lack thereof). Curr HIV /AIDS Rep. 2010 ; 7 (4). 245-252
32. Sterne JA, May M, Costagliola D, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009 ; 373 (9672). 1352-1363
33. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009 ; 360 (18). 1815-1826
34. El-Sadr WM, Affrunti M, Gamble T, Zerbe A. Antiretroviral therapy: a promising HIV prevention strategy?. J Acquir Immune Defic Syndr. 2010 ; 55 (suppl 2). S116 - S121
35. Dombrowski JC, Kitahata MM, Van Rompaey SE, et al. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. J Acquir Immune Defic Syndr. 2013 ; 63 (3). 299-306
36. Millett GA, Peterson JL, Flores SA, et al. Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysis. Lancet. 2012 ; 380 (9839). 341-348
37. Aidala AA, Lee G, Abramson DM, Messeri P, Siegler A. Housing need, housing assistance, and connection to HIV medical care. AIDS Behav. 2007 ; 11 (6 suppl). 101-115
38. Magnus M, Kuo I, Shelley K, et al. Risk factors driving the emergence of a generalized heterosexual HIV epidemic in Washington, District of Columbia networks at risk. AIDS. 2009 ; 23 (10). 1277-1284
39. Cargill VA, Stone VE. HIV/AIDS: a minority health issue. Med Clin North Am. 2005 ; 89 (4). 895-912
40. Mocroft A, Kirk O, Aldins P, et al. Loss to follow-up in an international, multicentre observational study. HIV Med. 2008 ; 9 (5). 261-269
41. Wood E, Kerr T, Zhang R, et al. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users. HIV Med. 2008 ; 9 (7). 503-507
42. Lodwick RK, Sabin CA, Porter K, et al. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. Lancet. 2010 ; 376 (9738). 340-345
43. Kerr T, Marshall A, Walsh J, et al. Determinants of HAART discontinuation among injection drug users. AIDS Care. 2005 ; 17 (5). 539-549
44. Purcell DW, Metsch LR, Latka M, et al. Interventions for seropositive injectors-research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. J Acquir Immune Defic Syndr. 2004 ; 37 (suppl 2). S110 - S118
45. Roux P, Carrieri MP, Cohen J, et al. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clin Infect Dis. 2009 ; 49 (9). 1433-1440
46. Semba RD, Ricketts EP, Mehta SF, et al. Adherence and retention of female injection drug users in a phase III clinical trial in inner city Baltimore. Am J Drug Alcohol Abuse. 2007 ; 33 (1). 71-80
47. Ashman JJ, Conviser R, Pounds MB. Associations between HIV-positive individuals' receipt of ancillary services and medical care receipt and retention. AIDS Care. 2002 ; 14 (suppl 1). S109 - S118
48. Hessol NA, Weber KM, Holman S, et al. Retention and attendance of women enrolled in a large prospective study of HIV-1 in the United States. J Womens Health (Larchmt). 2009 ; 18 (10). 1627-1637
49. Jenness SM, Myers JE, Neaigus A, Lulek J, Navejas M, Raj-Singh S. Delayed entry into HIV medical care after HIV diagnosis: risk factors and research methods. AIDS Care. 2012 ; 24 (10). 1240-1248
50. Mugavero MJ, Lin HY, Allison JJ, et al. Failure to establish HIV care: characterizing the "no show" phenomenon. Clin Infect Dis. 2007 ; 45 (1). 127-130
51. Samet JH, Freedberg KA, Stein MD, et al. Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med. 1998 ; 158 (7). 734-740
52. De Cock KM, El-Sadr WM. When to start ART in Africa - an urgent research priority. N Engl J Med. 2013 ; 368 (10). 886-889
53. Buchacz K, Armon C, Palella F, et al. CD4 cell counts at HIV diagnosis among HIV outpatient study participants, 2000-2009. AIDS Res Treat. 2012 ; 2012: 869841
54. Zuniga JM, Young B. Achieving improvements accross the HIV treatment cascade: a clinical management algorithm based on IAPAC's entry into and retention in care and antiretroviral therapy adherence guidelines. J Int Assoc Provid AIDS Care. 2013 ; 12 (1). 15-17
55. Giordano TP. Retention in HIV care: what the clinician needs to know. Top Antivir Med. 2011 ; 19 (1). 12-16
56. Tobias C, Cunningham WE, Cunningham CO, Pounds MB. Making the connection: the importance of engagement and retention in HIV medical care. AIDS Patient Care STDS. 2007 ; 21 (suppl 1). S3 - S8
57. Hall HI, Frazier EL, Rhodes P, et al. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med. 2013 ; 173 (14). 1337-1344